CompletedPhase 1NCT01150565

Safety Study of LiRIS in Interstitial Cystitis (IC) Patients

Studying Interstitial cystitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Allergan
Principal Investigator
Curtis Nickel, MD, MSN NP
Queen's University/Kingston General Hospital
Intervention
LiRIS low dose and LiRIS high dose(drug)
Enrollment
18 enrolled
Eligibility
18 years · FEMALE
Timeline
20102011

Study locations (3)

Collaborators

TARIS Biomedical, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01150565 on ClinicalTrials.gov

Other trials for Interstitial cystitis

Additional recruiting or active studies for the same condition.

See all trials for Interstitial cystitis

← Back to all trials